Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Serino (Braga, Portugal), C. Sousa (Porto, Portugal), M. Redondo (Porto, Portugal), N. Martins (Porto, Portugal), A. Amorim (Porto, Portugal). Are COPD patients with Nocardia species identification different from those who have also co-morbid bronchiectasis?. 2367

Member's Comments

No comment yet.

Related content which might interest you: Tsukamurella species isolation in bronchiectasis and chronic obstructive pulmonary disease patients: A retrospective case series Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Impact of comorbid bronchiectasis on COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Occurrence and impact of bronchiectasis in patients with COPD Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Prevalence of bronchiectasis in stable COPD outpatients Source: Eur Respir J 2004; 24: Suppl. 48, 58s Year: 2004 Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Bronchiectasis prevalence and relationship with clinical features in COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence? Source: Eur Respir J 2002; 19: 387-389 Year: 2002 A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Analysis of microbiological colonization in COPD patients with or without bronchiectasis Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD exacerbations Year: 2014 Non-CF bronchiectasis, an obstructive disease. Similarities with COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 High mortality in COPD patients with isolation of aspergillus spp in bronchial secretions Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013